Maternal-Newborn Nursing · Prenatal Testing

Prenatal Testing during the First Trimester

10 min read

On this page 9 sections

In 30 seconds
Why this matters
The college version
Eli explains
Worked example
Key takeaway
Check yourself
Study tools
Sources & references

In 30 seconds

The first trimester — roughly the first 13 weeks — is when prenatal testing does two very different jobs. First, it establishes the baseline: confirming the pregnancy is in the uterus, dating it accurately, checking blood type and general health, and screening for infections that can be treated during pregnancy. Second, it offers early screening for chromosomal conditions using ultrasound and blood tests, plus — for those who choose it — diagnostic testing through .

The single most important concept is the difference between screening and diagnostic testing. Screening tests estimate risk for everyone; diagnostic tests give a definitive answer. Almost everything in the first trimester is screening — a feature, not a failure, because screening is noninvasive and available to all. Understanding what each test can and cannot say is the foundation of honest patient education and informed decision-making.

Why this matters

Gestational age established now anchors every later test. First-trimester dating ultrasound is the most accurate dating method; all later screening windows and growth assessments depend on it.
Some conditions are treatable in pregnancy — but only if found early. Screening for HIV, syphilis, and hepatitis B early allows treatment that substantially reduces transmission to the fetus.
Knowing the Rh blood type early identifies Rh-negative pregnant people who may need preventive treatment later (anti-D immune globulin per protocol) to protect future pregnancies.
Chromosomal screening offered early gives families more time to gather information and make decisions — and, combined with second-trimester results, produces the most accurate risk estimates.
The nurse is the explainer. Patients routinely confuse screening with diagnosis; clear, non-directive education is a core nursing responsibility.

The college version

Core Concepts

Screening vs. diagnostic testing — learn this first

Screening tests (ultrasound, serum markers, cell-free DNA) are offered to everyone. They estimate risk — "higher" or "lower than average" — but do not diagnose. A "positive" screen means the person should be offered further testing and counseling, not that the fetus has a condition.
Diagnostic tests (CVS in the first trimester; amniocentesis in the second) analyze fetal or placental cells directly for a definitive chromosomal answer. They carry a small risk of procedure-related complications, which is why they are offered — not required — and preceded by counseling.

Screens are deliberately designed to catch more than they should — a "screen positive" occurs in a small percentage of healthy pregnancies by design, because that is how a screen keeps its sensitivity. Never present a screen result as a diagnosis.

Baseline laboratory tests at the first prenatal visit

Typical baseline panels (varying by institution, state, and country) include blood type and Rh type plus an antibody screen (identifies Rh-negative status and blood-group antibodies), complete blood count (anemia), urinalysis, and infection screening — commonly HIV, syphilis, and hepatitis B (often hepatitis C, rubella immunity, and others per local guidelines). Early detection is the point: several infections are treatable in pregnancy in ways that protect the fetus. The nurse explains why each test is done, supports informed consent per policy, and coordinates collection and result communication.

First-trimester ultrasound: dating, viability, and nuchal translucency

Dating — measuring the embryo's crown-rump length gives the most accurate gestational age early in pregnancy.
Viability — confirming the pregnancy is intrauterine with cardiac activity present.
Number of fetuses — identifying twins or more.
— measurement of the clear fluid space at the back of the fetal neck, taken in a narrow window around 11–13 weeks. A larger-than-expected NT is a risk marker for chromosomal conditions and some heart defects — not a diagnosis. Increased NT prompts counseling and further testing options.

Combined first-trimester screening (NT + serum markers)

The standard early screen for chromosomal conditions combines three pieces of information: the NT ultrasound measurement, levels of two proteins in the pregnant person's blood (PAPP-A and a form of hCG), and maternal age. The result is an individualized risk estimate (often expressed as a ratio such as 1 in X) for conditions like trisomy 21 and trisomy 18/13. The test is only valid within its timing window — another reason accurate dating matters. Abnormal levels do not diagnose; they change the risk estimate and open the door to further testing.

Cell-free DNA screening (cfDNA / NIPT)

Cell-free DNA screening — often called NIPT (noninvasive prenatal testing) — analyzes small fragments of placental DNA circulating in the pregnant person's blood. It screens for the common trisomies (21, 18, 13) and, in some panels, sex-chromosome conditions. It is highly sensitive for the conditions it targets, but it is still a : results are risk estimates, and positive results should be confirmed with a before any irreversible decision. Availability and coverage vary.

Carrier screening

looks for gene variants the pregnant person or their partner may carry for recessive conditions (cystic fibrosis, sickle cell disease, thalassemia, Tay–Sachs, and others depending on ancestry and panel). It does not test the fetus — it identifies whether the couple is at increased risk of having an affected child. It is most useful before pregnancy and is also offered early in pregnancy; results come with genetic counseling about recurrence risk and options.

Chorionic villus sampling (CVS): the first-trimester diagnostic test

CVS obtains a small sample of chorionic villi (placental tissue, which shares the fetus's genetic makeup) — via a catheter through the cervix or a needle through the abdomen, under ultrasound guidance — for a definitive chromosomal answer. Because it can be done around 10–13 weeks, CVS provides definitive information earlier than amniocentesis. It is invasive, with a small risk of complications including pregnancy loss, so it is offered with counseling and the choice is entirely the pregnant person's. Providers perform the procedure; the nurse prepares, educates, supports consent, and monitors afterward.

The nursing role across first-trimester testing

Educate before and after every test: what it measures, what it can't tell, what a screen-positive means, and what the next options are.
Support informed, non-directive decision-making — the pregnant person's values guide choices.
Coordinate scheduling, labs, and referrals to genetic counseling when results warrant; document and communicate results per facility policy.
Respect privacy and scope: interpretation, diagnosis, and management belong to the provider; nurses explain and support. Testing menus and protocols vary by institution and jurisdiction.

Common Confusions

Do not confuse	With	Difference
cfDNA/NIPT	A diagnostic test	NIPT is highly sensitive screening; positive results must be confirmed with CVS or amniocentesis
A "normal" screening result	A guarantee of a healthy baby	Screens cover specific conditions only; many problems are not screened for at all
Increased nuchal translucency	A diagnosis of Down syndrome	NT is a risk marker; it increases risk but does not diagnose
CVS	Amniocentesis	CVS samples placental tissue in the first trimester (~10–13 weeks); amniocentesis samples amniotic fluid in the second
Carrier screening	Testing the fetus	Carrier screening tests the parents' own gene variants to estimate recurrence risk
The same test menu for everyone	Risk-based and institutional variation	Which tests are offered, and when, follows guidelines and local policy; screening is optional

Eli explains

The same idea, in plain words

Explain it like I’m 10

Early pregnancy tests are like a mechanic checking a brand-new car before a long trip. First the mechanic measures and dates everything (the ultrasound), checks the oil and fluids (the blood tests), and looks for warning lights. Most checks are "so far, so good." Some checks only say "keep an eye on this" — not that anything is wrong — and if a check says that, the family can choose to do a more exact test. Most cars finish the trip just fine.

Worked example

A 34-year-old pregnant person at 9 weeks has her first prenatal visit. The nurse explains the baseline labs — blood type and Rh, CBC, urinalysis, infection screening. "Why all these?" she asks. The nurse explains that some results change care during pregnancy: knowing she is Rh-negative means a preventive treatment later per protocol, and treating an infection early protects the baby. She consents.

At 12 weeks, dating ultrasound and nuchal translucency are done, and blood is drawn for the combined first-trimester screen. A week later the result comes back: the risk estimate for trisomy 21 is higher than average. The nurse's response models how a screen-positive should be handled:

Clarify what the result means: "This is a risk estimate, not a diagnosis. Most pregnancies with results like this do not have the condition — but the number tells us more information would be helpful."
Offer the path forward: genetic counseling and options including cfDNA or a diagnostic test (CVS now, or amniocentesis later).
Support the decision: no pressure, no persuasion — the patient chooses what fits her values. The nurse coordinates the genetics referral and stays available for questions.

Why this works: the nurse separated the fact (an elevated risk estimate) from the meaning (an option to learn more), never presented screening as diagnosis, and kept the decision with the family.

Key takeaways

Screening ≠ diagnosis. Only CVS gives a definitive chromosomal answer in the first trimester.
NT measurement has a narrow window (~11–13 weeks) — accurate dating makes screening valid.
Combined first-trimester screening = NT ultrasound + serum markers (PAPP-A and hCG) + maternal age → individualized risk estimate.
cfDNA/NIPT is highly sensitive but still screening — positive results need confirmatory diagnostic testing.
CVS is the first-trimester diagnostic option (placental tissue, ~10–13 weeks); amniocentesis is the second-trimester option (next topic).
Baseline labs at the first visit include blood type/Rh, antibody screen, CBC, urinalysis, and infection screening — early treatment of HIV and syphilis reduces fetal transmission.
Rh-negative status identified early allows anti-D immune globulin per protocol at the appropriate times.
Carrier screening tells parents about their own gene variants and recurrence risk — ideally before pregnancy.
Interpretation and management are provider roles; the nurse educates, supports, coordinates, and documents. Protocols vary by institution.

Check yourself

6 review questions from the chapter. Try each one, then open the answer.

What is the difference between a screening test and a diagnostic test? Give one example of each from the first trimester.
Show answer
A screening test estimates risk and is offered to everyone (e.g., combined first-trimester screening, cfDNA, NT ultrasound). A diagnostic test gives a definitive answer by analyzing fetal/placental cells (e.g., CVS) and is offered with counseling because it is invasive.
What three pieces of information go into the ?
Show answer
The nuchal translucency ultrasound measurement, maternal serum markers (PAPP-A and hCG), and maternal age — combined into an individualized risk estimate.
A cfDNA (NIPT) result comes back "positive" for trisomy 21. What should the nurse tell the pregnant person?
Show answer
Explain that a positive screening result is a risk estimate, not a diagnosis; most screen-positive pregnancies do not have the condition. Offer genetic counseling and confirmatory diagnostic testing (CVS now or amniocentesis later), supporting whatever choice the family makes — non-directively.
Why is the nuchal translucency measurement only valid within a narrow gestational-age window?
Show answer
Because fetal anatomy and fluid patterns change rapidly in early pregnancy; the measurement is standardized for a specific developmental window (~11–13 weeks), so accurate dating is required for the result to be meaningful.
What is the purpose of baseline infection screening at the first prenatal visit?
Show answer
To find infections that can be treated during pregnancy — treating HIV, syphilis, and hepatitis B early substantially reduces transmission to the fetus. Early detection is what makes prevention possible.
Why is carrier screening ideally done before pregnancy?
Show answer
Because carrier screening identifies the couple's risk of passing on recessive conditions, and knowing that before conception gives the fullest range of reproductive options and time for decisions. It is also offered early in pregnancy when not done beforehand.

Keep learning

Ready to build on this? Continue to the next lesson.

Study tools & related lessonsKey vocabulary · Related

Key vocabulary

Screening test: A test offered to everyone that estimates risk for a condition
Diagnostic test: A test that analyzes fetal/placental cells for a definitive answer
Nuchal translucency (NT): Ultrasound measurement of fluid at the back of the fetal neck (~11–13 weeks)
Combined first-trimester screening: NT + maternal serum markers (PAPP-A, hCG) + maternal age → risk estimate
Cell-free DNA (cfDNA/NIPT): Blood test analyzing placental DNA fragments for trisomy risk
Carrier screening: Testing parents for gene variants of recessive conditions
Chorionic villus sampling (CVS): First-trimester diagnostic sampling of placental tissue
Baseline labs: Initial blood/urine panel at the first prenatal visit
PAPP-A / hCG: Serum markers measured in first-trimester screening

Sources & references

openstax.org — Maternal Newborn Nursing

This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.

Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.